In this study, we employed an APP/PS1 transgenic mouse model that developed age-related accumulation of plaques and tangles in the brain, showing some symptoms related to AD, to test the hypothesis that SA could be effective in treating AD. The gene discussed is APP; the disease is Alzheimer disease.